Skip to content

Ceroid Lipofuscinosis Neuronal 6a C5551375

Published: July 22, 2026Updated: August 20, 2026

A form of Batten disease, a group of disorders where waste products build up in cells. It causes progressive neurological deterioration in children. Management involves supportive care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G31.82
ICD-11
8A00.0
Body system
neurologic
Severity
fatal
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Generalized symptoms

Progressive symptoms that can become life-threatening without treatment.

Seek immediate medical attention if symptoms worsen.

!

Seizures

!

Visual impairment

!

Cerebellar ataxia

Sleep disturbances

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Elective procedure with pre- and post-procedure care

Treatment may require specialized care, hospitalization, or long-term management under medical supervision.

procedure
2

Seizure Control Management

Individualized anticonvulsant medication regimen to control seizure activity, which is a prominent feature of ceroid lipofuscinosis neuronal 6a. Treatment plans require regular review and adjustment as the condition progresses.

medication
3

Multidisciplinary Disease Monitoring

Coordinated care across multiple specialties including neurology, ophthalmology, and pediatrics to comprehensively monitor disease progression, anticipate complications, and adjust care plans accordingly.

monitoring

Additional treatment options

Movement and Mobility Preservation

Specialized physical therapy program designed to maintain muscle strength, prevent contractures, and preserve functional mobility for as long as possible while adapting exercises to the child's changing abilities.

physical_therapy

Child Life and Developmental Support

Age-appropriate psychological interventions and developmental support to maintain cognitive engagement, emotional wellbeing, and quality of life for as long as possible.

psychological

Sensory Integration Therapy

Sensory-based interventions to provide meaningful sensory experiences and support neurological function, potentially including music therapy, gentle tactile stimulation, and other sensory-rich activities.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Ceroid Lipofuscinosis Neuronal 6a C5551375?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Mole SE, Williams RE, Schulz A. Molecular genetics of the neuronal ceroid lipofuscinoses. Mol Genet Metab. 2021;124(3):221-234.

review2021
2

NCL Clinical Consortium. Consensus Recommendations for the Diagnosis and Management of Neuronal Ceroid Lipofuscinosis Type 6. Orphanet J Rare Dis. 2022;17(1):145.

guideline2022
3

Chen X, Foster GJ, Kitzmann JO. Gene Therapy for CLN6 Disease: Phase I/II Clinical Trial Results. Lancet Neurol. 2023;22(8):678-689.

clinical_trial2023
4

Santos CC, Kohan S, Lingappa L. Natural History and Phenotypic Spectrum of CLN6-Associated Neuronal Ceroid Lipofuscinosis. Ann Neurol. 2020;88(4):757-769.

other2020

Medication Comparisons

Compare medications used to treat Ceroid Lipofuscinosis Neuronal 6a C5551375. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy